Advanced search
Publication Cover
Expert Review of Endocrinology & Metabolism Volume 7, 2012 - Issue 5
Submit an article Journal homepage
57
Views
1
CrossRef citations to date
0
Altmetric
Drug Profile

Phentermine plus topiramate for the treatment of obesity

Amanda Powell Boston University School of Medicine, 88 East Newton Street Robinson Building, Suite 4400, Boston, MA 02118, USA. [email protected]; Boston University School of Medicine, Center for Nutrition and Weight Management, Boston Medical Center, 88 East Newton Street Robinson Bldg. Suite 4400, Boston, MA 02118, USA; Boston University School of Medicine, 88 East Newton Street Robinson Building, Suite 4400, Boston, MA 02118, USA. [email protected]
,
Louis J Aronne Weill-Cornell Medical College, 1165 York Ave, NY 10065, USA; Weill-Cornell Medical College, 1165 York Ave, NY 10065, USA
&
Caroline M Apovian Boston University School of Medicine, Center for Nutrition and Weight Management, Boston Medical Center, 88 East Newton Street Robinson Bldg. Suite 4400, Boston, MA 02118, USA; Boston University School of Medicine, Center for Nutrition and Weight Management, Boston Medical Center, 88 East Newton Street Robinson Bldg. Suite 4400, Boston, MA 02118, USA
Pages 503-510 | Published online: 10 Jan 2014

References

  • Barness LA, Opitz JM, Gilbert-Barness E. Obesity: genetic, molecular, and environmental aspects. Am. J. Med. Genet. A 143A(24), 3016–3034 (2007).
  • Whitlock G, Lewington S, Sherliker P et al.; Prospective Studies Collaboration. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 373(9669), 1083–1096 (2009).
  • Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 307(5), 491–497 (2012).
  • Knowler WC, Barrett-Connor E, Fowler SE et al.; The Diabetes Prevention Program Research Group. Reduction in the incidence of Type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 346, 393–403 (2002).
  • Leblanc ES, O’Connor E, Whitlock EP, Patnode CD, Kapka T. Effectiveness of primary care-relevant treatments for obesity in adults: a systematic evidence review for the U.S. Preventive Services Task Force. Ann. Intern. Med. 155(7), 434–447 (2011).
  • Melnikova I, Wages D. Anti-obesity therapies. Nat. Rev. Drug Discov. 5(5), 369–370 (2006).
  • Foxcroft DR, Milne R. Orlistat for the treatment of obesity: rapid review and cost-effectiveness model. Obes. Rev. 1(2), 121–126 (2000).
  • Powell AG, Apovian CM, Aronne LJ. New drug targets for the treatment of obesity. Clin. Pharmacol. Ther. 90(1), 40–51 (2011).
  • Aronne LJ, Halseth AE, Burns CM, Miller S, Shen LZ. Enhanced weight loss following coadministration of pramlintide with sibutramine or phentermine in a multicenter trial. Obesity (Silver Spring). 18(9), 1739–1746 (2010).
  • Shank RP, Maryanoff BE. Molecular pharmacodynamics, clinical therapeutics, and pharmacokinetics of topiramate. CNS Neurosci. Ther. 14(2), 120–142 (2008).
  • Topamax, package insert. Janssen Pharmaceuticals, NJ, USA.
  • Appolinario JC, Bueno JR, Coutinho W. Psychotropic drugs in the treatment of obesity: what promise? CNS Drugs 18(10), 629–651 (2004).
  • Bray GA, Hollander P, Klein S et al. A 6 month randomized, placebo-controlled dose-ranging trial of Topiramate for weight loss in obesity. Obes. Res. 11, 722–733 (2003).
  • Coman E. Anorectics on trial; a half century of regulation of prescription appetite suppressants. Ann. Intern. Med. 143(5), 380–385 (2005).
  • VI-0521 (QNEXA®) Advisory Committee Briefing Document, NDA 022580, Vivus, Inc., 15 July 2010.
  • Supuran CT, Di Fiore A, De Simone G. Carbonic anhydrase inhibitors as emerging drugs for the treatment of obesity. Expert Opin. Emerg. Drugs 13(2), 383–392 (2008).
  • Astrup A, Toubro S. Topiramate: a new potential pharmacological treatment for obesity. Obes. Res. 12(Suppl.), S167–S173 (2004).
  • VI-0521 (Qnexa®) Advisory Committee Briefing Document NDA 022580, Vivus Pharmaceuticals, 22 February 2012.
  • Allison DB, Gadde KM, Garvey WT et al. Controlled release phentermine/topiramate in severely obese adults: a randomized controlled trial (EQUIP). Obesity 20(2), 330–342 (2012).
  • Gadde KM, Allison DB, Ryan DH et al. Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, Phase 3 trial. Lancet 377(9774), 1341–1352 (2011).
  • Garvey WT, Ryan DH, Look M et al. Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, Phase 3 extension study. Am. J. Clin. Nutr. 95(2), 297–308 (2012).
  • White WB. Heart rate and rate-pressure product as determinants of cardiovascular risk in patients with hypertension. Am. J. Hypertens. 12(2), S50–S55 (1999).
  • Vajda FJE, Graham J, Roten A, Lander CM, O’Brien TJ, Eadie, M. Teratogenicity of newer antiepileptic drugs, the Australian experience. J. Clin. Neurophysiol. 19(1), 57–59 (2012).
  • Sjöström L, Narbro K, Sjöström CD et al.; Swedish Obese Subjects Study. Effects of bariatric surgery on mortality in Swedish obese subjects. N. Engl. J. Med. 357(8), 741–752 (2007).
  • Weintraub M, Hasday JD, Mushlin AI, Lockwood DH. A double-blind clinical trial in weight control. Use of fenfluramine and phentermine alone and in combination. Arch. Intern. Med. 144(6), 1143–1148 (1984).
  • Glazer, G. Long-term pharmacotherapy of Obesity 2000. Arch. Intern. Med. 161(15), 1814–1824 (2001).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.